These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
726 related articles for article (PubMed ID: 16795981)
1. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981 [TBL] [Abstract][Full Text] [Related]
2. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients. Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564 [TBL] [Abstract][Full Text] [Related]
3. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B; Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396 [TBL] [Abstract][Full Text] [Related]
4. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143 [TBL] [Abstract][Full Text] [Related]
6. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center. Banerjee S; Bishop WP J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954 [TBL] [Abstract][Full Text] [Related]
7. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity. Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961 [TBL] [Abstract][Full Text] [Related]
8. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold. Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186 [TBL] [Abstract][Full Text] [Related]
10. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A; Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852 [TBL] [Abstract][Full Text] [Related]
12. Mistaken identity: misclassification of TPMT phenotype following blood transfusion. Cheung ST; Allan RN Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1245-7. PubMed ID: 14560161 [TBL] [Abstract][Full Text] [Related]
13. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197 [TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Dubinsky MC; Reyes E; Ofman J; Chiou CF; Wade S; Sandborn WJ Am J Gastroenterol; 2005 Oct; 100(10):2239-47. PubMed ID: 16181376 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease. Kim DU; Kim YH; Kim BJ; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC Hepatogastroenterology; 2009; 56(94-95):1395-402. PubMed ID: 19950798 [TBL] [Abstract][Full Text] [Related]
18. Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine. van Asseldonk DP; Kanis BM; de Boer NK; van Bodegraven AA Digestion; 2009; 79(4):211-4. PubMed ID: 19390192 [TBL] [Abstract][Full Text] [Related]